Indicated for: hypertension
Substance: olmesartan medoxomil + amlodipine (antihypertensive + calcium channel blocker)
ATC: C09DB02 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers)
This combination of olmesartan medoxomil and amlodipine is used for the treatment of hypertension in patients not adequately controlled with a single medication. Olmesartan blocks angiotensin II receptors, while amlodipine is a calcium channel blocker that relaxes blood vessels.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as dizziness, edema, or headaches. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, edema, headaches, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
Price
Copayment
Patient
61.02 RON
23.82 RON
37.20 RON